Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

TALARIS THERAPEUTICS, INC.

(TALS)
  Rapport
Geschatte realtime Cboe BZX  -  19:45:43 30-01-2023
1.580 USD   +17.91%
2022Talaris Therapeutics, Inc. rapporteert resultaten voor het derde kwartaal eindigend op 30 september 2022
CI
2022Talaris Therapeutics, Inc. Presenteert gegevens over mechanismen van Fcr001-activiteit om immuuntolerantie te induceren
CI
2022Talaris Therapeutics, Inc. : HC Wainwright herhaalt koopadvies
MM
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
ETF's gepositioneerd op TALARIS THERAPEUTICS, INC.ETF's en trackers met Trackinsight
ETF gewichtVariatie 5 dagenRatingGeografie
IShares Micro-Cap ETF - USD0.02%1.46%VS
Invesco Nasdaq Biotechnology ETF - USD0.01%1.11%-VS
IShares Nasdaq US Biotechnology (D) - USD0.01%1.83%VS
IShares Nasdaq US Biotechnology - USD0.01%1.78%VS
IShares Biotechnology ETF - USD0.01%1.30%-NC
IShares Russell 2000 Value ETF - USD0.01%2.26%VS
Vanguard Russell 2000 Value ETF - USD0.01%2.23%VS
Vanguard Russell 2000 ETF - USD0%2.46%VS
Xtrackers Russell 2000 1C - USD0%2.49%VS



Copyright © 2009 Morningstar. All Rights Reserved. The information, data and opinions expressed (ďInformationĒ) and contained herein: (1) are proprietary to Morningstar and/or its content providers and are not intended to represent investment advice or recommendation to buy or sell any security; (2) may not be copied or distributed without express license to do so; and (3) are not warranted to be accurate, complete or timely. Morningstar reserve its rights to charge for access to these Ratings and/or Rating report. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this Rating, Rating Report or Information contained therein.
Grafiek TALARIS THERAPEUTICS, INC.
Duur : Periode :
Talaris Therapeutics, Inc. : Grafische technische analyse Talaris Therapeutics, Inc. | MarketScreener
Grafiek op volledig scherm
Evolutie van de resultatenrekening
Consensus
Verkoop
Koop
Gemiddeld advies Accumuleren
Aantal analisten 5
Laatste slotkoers 1,34 $
Gemiddelde koersdoel 9,00 $
Spread / Gemiddelde doel 572%
Grafiek TALARIS THERAPEUTICS, INC.
Duur : Periode :
Talaris Therapeutics, Inc. : Grafische technische analyse Talaris Therapeutics, Inc. | MarketScreener
Grafiek op volledig scherm
Sector en concurrentie
Verschil t.o.v. 1 jan (%)Kapitalisatie (M$)
TALARIS THERAPEUTICS, INC.31.37%56
MODERNA, INC.5.42%72 745
LONZA GROUP AG17.24%42 787
IQVIA HOLDINGS INC.12.00%42 622
ALNYLAM PHARMACEUTICALS, INC.-2.64%28 465
SEAGEN INC.9.46%26 117